PHARMA MAR, S.A. «...678910...» Page 9 out of 24 05/07/2023 17:42 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company reports details of the operations of the Liquidity Agreement between 01/04/2023 and 30/06/2023 Register number: 23453 06/06/2023 14:26 PHARMA MAR, S.A. On business and financial situation The Company announces together with its partner Luye Pharma Group Ltd. the acceptance of New Drug Application for lurbinectedin in China. Register number: 22872 31/05/2023 13:51 PHARMA MAR, S.A. Other relevant information The Company informs about the dividend payment Register number: 22801 31/05/2023 13:30 PHARMA MAR, S.A. On corporate governance The Company reports changes in the composition of its Board of Directors and its Committees. Register number: 22800 31/05/2023 13:19 PHARMA MAR, S.A. Announcement of general shareholders’ meeting It is reported that all proposed resolutions submitted by the Board to the General Shareholders’ Meeting have been approved. Register number: 22799 31/05/2023 11:15 PHARMA MAR, S.A. Announcement of general shareholders’ meeting Attached is a copy of the presentation to shareholders to be made at the General Shareholders’ Meeting of Pharma Mar by the Chairman and by the Chief Financial Officer of the Company. Register number: 22794 04/05/2023 09:04 PHARMA MAR, S.A. On business and financial situation Press release informing about the recruitment of the first patient in a new Phase I clinical trial for the treatment of patients with different types of solid tumors with its new molecule of marine origin: PM54 Register number: 22330 26/04/2023 18:12 PHARMA MAR, S.A. Announcement of general shareholders’ meeting The Company announces the call of the Ordinary General Shareholders’ Meeting and submits proposed resolutions. Register number: 22126 26/04/2023 18:05 PHARMA MAR, S.A. On corporate governance The Company informs about the resignation of a director and changes in the composition of the Board of Directors and its Committees. Register number: 22124 26/04/2023 17:57 PHARMA MAR, S.A. Other relevant information - On business and financial situation The Company files first quarter 2023 financial information and announces a conference call with analysts and investors. Register number: 22122 Page 9 out of 24 «...678910...»
